CTXR
Price
$3.30
Change
+$0.04 (+1.23%)
Updated
Jan 17 closing price
Capitalization
27.95M
20 days until earnings call
VERV
Price
$6.14
Change
+$0.04 (+0.66%)
Updated
Jan 17, 04:59 PM (EDT)
Capitalization
519.84M
39 days until earnings call
Ad is loading...

CTXR vs VERV

Header iconCTXR vs VERV Comparison
Open Charts CTXR vs VERVBanner chart's image
Citius Pharmaceuticals
Price$3.30
Change+$0.04 (+1.23%)
Volume$78.6K
Capitalization27.95M
Verve Therapeutics
Price$6.14
Change+$0.04 (+0.66%)
Volume$31.47K
Capitalization519.84M
CTXR vs VERV Comparison Chart
Loading...
CTXR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CTXR vs. VERV commentary
Jan 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CTXR is a Hold and VERV is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 18, 2025
Stock price -- (CTXR: $3.26 vs. VERV: $6.10)
Brand notoriety: CTXR and VERV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CTXR: 29% vs. VERV: 110%
Market capitalization -- CTXR: $27.95M vs. VERV: $519.84M
CTXR [@Biotechnology] is valued at $27.95M. VERV’s [@Biotechnology] market capitalization is $519.84M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CTXR’s FA Score shows that 1 FA rating(s) are green whileVERV’s FA Score has 0 green FA rating(s).

  • CTXR’s FA Score: 1 green, 4 red.
  • VERV’s FA Score: 0 green, 5 red.
According to our system of comparison, both CTXR and VERV are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CTXR’s TA Score shows that 3 TA indicator(s) are bullish while VERV’s TA Score has 3 bullish TA indicator(s).

  • CTXR’s TA Score: 3 bullish, 4 bearish.
  • VERV’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, both CTXR and VERV are a bad buy in the short-term.

Price Growth

CTXR (@Biotechnology) experienced а -12.13% price change this week, while VERV (@Biotechnology) price change was +1.50% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.05%. For the same industry, the average monthly price growth was +3.04%, and the average quarterly price growth was -1.59%.

Reported Earning Dates

CTXR is expected to report earnings on Feb 07, 2025.

VERV is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (-1.05% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VERV($520M) has a higher market cap than CTXR($28M). VERV YTD gains are higher at: 8.156 vs. CTXR (-18.500). VERV has more cash in the bank: 540M vs. CTXR (212). CTXR has less debt than VERV: CTXR (320K) vs VERV (71.3M).
CTXRVERVCTXR / VERV
Capitalization28M520M5%
EBITDAN/A-219.97M-
Gain YTD-18.5008.156-227%
P/E RatioN/AN/A-
RevenueN/A24.4M-
Total Cash212540M0%
Total Debt320K71.3M0%
FUNDAMENTALS RATINGS
CTXR: Fundamental Ratings
CTXR
OUTLOOK RATING
1..100
23
VALUATION
overvalued / fair valued / undervalued
1..100
10
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CTXRVERV
RSI
ODDS (%)
Bullish Trend 5 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 5 days ago
89%
Bullish Trend 5 days ago
81%
Momentum
ODDS (%)
Bearish Trend 5 days ago
81%
Bearish Trend 5 days ago
90%
MACD
ODDS (%)
N/A
Bearish Trend 5 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
86%
Bearish Trend 5 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
83%
Bearish Trend 5 days ago
88%
Advances
ODDS (%)
Bullish Trend 19 days ago
85%
Bullish Trend 12 days ago
87%
Declines
ODDS (%)
Bearish Trend 6 days ago
86%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 5 days ago
84%
N/A
View a ticker or compare two or three
Ad is loading...
CTXR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY591.64-1.14
-0.19%
SPDR® S&P 500® ETF Trust
BTC.X99756.910000-747.585940
-0.74%
Bitcoin cryptocurrency
GME27.72-0.24
-0.86%
GameStop Corp
TSLA413.82-14.40
-3.36%
Tesla
AAPL228.26-9.61
-4.04%
Apple

CTXR and

Correlation & Price change

A.I.dvisor indicates that over the last year, CTXR has been loosely correlated with EYEN. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if CTXR jumps, then EYEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTXR
1D Price
Change %
CTXR100%
-4.12%
EYEN - CTXR
45%
Loosely correlated
+0.15%
TFFP - CTXR
32%
Poorly correlated
N/A
VERV - CTXR
30%
Poorly correlated
+11.11%
ALEC - CTXR
29%
Poorly correlated
N/A
VYGR - CTXR
29%
Poorly correlated
-2.50%
More

VERV and

Correlation & Price change

A.I.dvisor indicates that over the last year, VERV has been loosely correlated with BEAM. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if VERV jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VERV
1D Price
Change %
VERV100%
+11.11%
BEAM - VERV
54%
Loosely correlated
+0.04%
CRSP - VERV
52%
Loosely correlated
+3.23%
PRME - VERV
49%
Loosely correlated
+0.35%
EDIT - VERV
49%
Loosely correlated
+1.64%
NTLA - VERV
48%
Loosely correlated
-2.99%
More